⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1033081 | 1.00 | — | — | |
| SCHEMBL1030842 | 1.00 | — | — | |
| SCHEMBL1028073 | 0.72 | — | — | |
| SCHEMBL1028570 | 0.72 | — | — | |
| SCHEMBL6968259 | 0.72 | — | — | |
| SCHEMBL20968 | 0.70 | — | — | |
| SCHEMBL2995 | 0.70 | — | — | |
| SCHEMBL28809843 | 0.70 | — | — | |
| SCHEMBL29035022 | 0.68 | — | — | |
| SCHEMBL28810326 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586264-A | Pyrrolo-ring compounds, and preparation method and application thereof | 成都微芯药业有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-116207349-A | Functional additive, electrolyte and lithium ion battery | 湖北亿纬动力有限公司 | 2023-06-02 | — | — | CN | claimed |
| US-10829516-B2 | Peptidomimetics for imaging the ghrelin receptor | LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) | 2020-11-10 | — | — | US | claimed |
| EP-3033343-B1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK | NOVARTIS AG (CH) | 2018-12-05 | — | — | EP | claimed |
| EP-2763987-B1 | HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE AS FUNGICIDALS | BAYER CROPSCIENCE AG (DE) | 2018-07-18 | — | — | EP | claimed |
| US-20170183348-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. | 2017-06-29 | — | — | US | claimed |
| EP-2763993-B1 | HETEROCYCLYLPYRI(MI)DINYLPYRAZOLE | BAYER IP GMBH (DE) | 2017-04-19 | — | — | EP | claimed |
| EP-3033343-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK | Novartis AG (CH) | 2016-06-22 | — | — | EP | claimed |
| US-20160136150-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF MEK | NOVARTIS AG (CH) | 2016-05-19 | — | — | US | claimed |
| US-9227969-B2 | Compounds and compositions as inhibitors of MEK | NOVARTIS AG (CH) | 2016-01-05 | — | — | US | claimed |
| US-20100240072-A1 | Cancer Imaging and Treatment | TECHNISCHE UNIVERSITAT MUNCHEN (DE) | 2010-09-23 | — | — | US | claimed |
| EP-2183272-A2 | RADIOLABELED MONOMERIC AND MULTIMERIC CYCLIC OLIGOPEPTIDES BINDING TO THE CXCR4 RECEPTOR FOR CANCER IMAGING AND TREATMENT | Technische Universität München (DE) | 2010-05-12 | — | — | EP | claimed |
| WO-2009027706-A2 | CANCER IMAGING AND TREATMENT | Technische Universität München (DE) | 2009-03-05 | — | — | WO | claimed |
| US-20090042957-A1 | Substituted Oxyarenes | BAYER CROPSCIENCE AG (DE) | 2009-02-12 | — | — | US | claimed |
| EP-1991562-A2 | CANCER IMAGING AND TREATMENT | Technische Universität München (DE) | 2008-11-19 | — | — | EP | claimed |
| WO-2007096662-A9 | CANCER IMAGING AND TREATMENT | UNIV MUENCHEN TECH (DE) | 2008-10-30 | — | — | WO | claimed |
| EP-1831145-A1 | SUBSTITUTED OXYARENES | Bayer CropScience Aktiengesellschaft (DE) | 2007-09-12 | — | — | EP | claimed |
| WO-2007096662-A2 | CANCER IMAGING AND TREATMENT | Technische Universität München (DE) | 2007-08-30 | — | — | WO | claimed |
| WO-2006069685-A1 | SUBSTITUTED OXYARENES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2006-07-06 | — | — | WO | claimed |
| EP-0668261-B1 | PROCESS FOR PRODUCING POLYFLUOROPROPIONYL HALIDE | AG TECHNOLOGY CORP (JP) | 1998-12-30 | — | — | EP | claimed |